RUNX3 and gastric cancer: Furthermore, miR-130a acts as an oncogene that promotes gastric cancer tumorigenesis by targeting the tumor-suppressor gene RUNX3. Thus, future studies on the anticancer mechanisms of miR-130a may contribute to the development of new therapeutic strategies for gastric cancer.